Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|November 18, 2023
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trialKamala Thriemer, Tamiru Shibiru Degaga, Michael Christian, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Plos Neglected Tropical Diseases|September 6, 2023
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiencyWalter R J Taylor, Niamh Meagher, Benedikt Ley, et al.
Malaria Journal|April 13, 2022
Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learningDebashish Das, Ranitha Vongpromek, Thanawat Assawariyathipat, et al.
The Lancet Regional Health. Western Pacific|June 22, 2026
High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of Plasmodium vivax malaria: a safety study in Papua New Guinea and IndonesiaLiony Fransisca, Maria Ome-Kaius, Moses Laman, et al.
Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
ESMO Open|August 30, 2017
The European Cancer Patient's Bill of Rights, update and implementation 2016Mark Lawler, Ian Banks, Kate Law, et al.
BMC Medicine|September 15, 2022
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient dataKasia Stepniewska, Elizabeth N Allen, Georgina S Humphreys, et al.
Lancet (London, England)|July 23, 2019
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trialWalter R J Taylor, Kamala Thriemer, Lorenz von Seidlein, et al.
Plos Medicine|July 25, 2020
Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysisDaniel A Pfeffer, Benedikt Ley, Rosalind E Howes, et al.
Pageof 20